Petra Capital Partners Raises $270M for Fifth Growth Fund
- Editor
- Jan 29
- 2 min read
Updated: Jan 29
What's Happening: Petra Capital Partners has completed fundraising for its fifth growth fund, Petra Growth Fund V (PGF V), raising $270 million. The fund was oversubscribed and reached its hard cap. PGF V will target healthcare, business, and technology-enabled services companies and is structured as a small business investment company (SBIC) licensed by the U.S. Small Business Administration.
The Key Moves:
PGF V raised $270 million, reaching its hard cap and oversubscribing.
The fund will focus on healthcare, business, and technology-enabled services companies.
PGF V has already made its first platform investment in a leading primary market research and analytics firm.
By The Numbers :
$270 million: Total capital raised for Petra Growth Fund V.
$25 million: Maximum investment per company for PGF V.
$900 million: Total capital deployed by Petra Capital Partners over 25 years.
Key Quotes:
"We are very pleased with the response from our existing investors and several important new investors for PGF V and the strong support we received from the SBIC program," said Mike Blackburn, Founding Managing Partner at Petra.
"We are excited to begin deploying PGF V and with increased capacity to invest per deal, Petra can support its companies longer in their life cycles with a combination of flexible debt and equity solutions," commented Doug Owen, Managing Partner at Petra.
"This new investment fits squarely into one of our core investment sectors of healthcare and pharma services and represents a compelling opportunity for the fund," commented David Fitzgerald, Managing Partner at Petra.
The Bottom Line: Petra Capital Partners' successful fundraising for PGF V demonstrates strong investor confidence in their strategy. With $270 million in capital and a focus on high-growth sectors, the fund is well-positioned to make significant investments in healthcare, business, and technology-enabled services companies. The firm's track record of deploying over $900 million across more than 100 high-growth companies over 25 years adds credibility to their investment approach.
Comments